Retraction
Treatment Protocols in the Efficacy and Safety of Anti-EGFR Medicines in Combination with Standard Therapy for Patients with Nasopharyngeal Cancer: A Meta-Analysis
Paper Information
Retraction Details
Retraction Reasons:
- Computer-Aided Content or Computer-Generated Content
- Concerns/Issues About Data
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues with Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Paper Mill
- Unreliable Results and/or Conclusions
Nature of Retraction:
Retraction
Retraction Notice:
10.1155/2023/9830710Additional Notes:
See also: https://pubpeer.com/publications/D1D37E76FFE9BF6CD374170B28F022
Citations (4)
4
Total Citations2
Post-Retraction(50.0%)
1
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
1
Within 1 year
0
After 2+ years
398
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Axl and EGFR Dual-Specific Binding Affibody for Targeted Therapy in Nasopharyngeal Carcinoma
Saidu Kamara, Wen He, Yanru Guo et al. (9 authors)
Cells
Open Access
Published: Nov 2024
398 days after retraction
Advances of radiotherapy combined with targeted therapy for nasopharyngeal carcinoma
Xiaoyan Xu, Hengzhao Zhuang, Yijun Xu et al. (6 authors)
Radiation Medicine and Protection
Open Access
Published: Oct 2023
2 citations
2 citations
3 days after retraction
Retracted: Treatment Protocols in the Efficacy and Safety of Anti-EGFR Medicines in Combination with Standard Therapy for Patients with Nasopharyngeal Cancer: A Meta-Analysis
BioMed Research International
BioMed Research International
Open Access
Published: Jan 2023
276 days before retraction
Quick Stats
Total Citations:
6
Years Since Retraction:
2.1 years
Open Access:
Yes
Last Checked:
Jul 24, 2025